<?xml version="1.0" encoding="utf-8"?>
<Document>
  <Do_id>15735135</Do_id>
  <Journal>Journal of clinical oncology : official journal of the American Society of Clinical Oncology</Journal>
  <Doc_title>CASE 3. Pathologic complete remission of metastatic gastrointestinal stromal tumor after imatinib mesylate.</Doc_title>
  <Doc_abstract>None</Doc_abstract>
  <Doc_ChemicalList>Antineoplastic Agents;Benzamides;Piperazines;Pyrimidines;Imatinib Mesylate</Doc_ChemicalList>
  <Doc_meshdescriptors>Antineoplastic Agents;Benzamides;Gastrointestinal Stromal Tumors;Humans;Imatinib Mesylate;Male;Middle Aged;Piperazines;Pyrimidines;Remission Induction</Doc_meshdescriptors>
  <Doc_meshqualifiers>therapeutic use;drug therapy;pathology;therapeutic use;therapeutic use</Doc_meshqualifiers>
</Document>
